Skip to main content
. 2022 May 21;12(5):675. doi: 10.3390/brainsci12050675
GBM glioblastoma
OS overall survival
UA univariate
MA multivariate
S + C + T Stupp + chemoradiotherapy + temozolomide
NLR neutrophil count/lymphocyte count
HR hazard ratio
CI confidence interval
NR not reported
NOS Newcastle-Ottawa quality assessment